| 1 |
Berry RG, Morrison JA, Watts JW, Anagnost JW, Gonzalez JJ. Surreptitious superwarfarin ingestion with brodifacoum. South Med J 2000;93:74-75.
DOI
|
| 2 |
Hadler MR, Shadbolt RS. Novel 4-hydroxycoumarin anticoagulants active against resistant rats. Nature 1975;253:275-277.
DOI
ScienceOn
|
| 3 |
Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2004;22:335-404.
DOI
ScienceOn
|
| 4 |
Spahr JE, Maul JS, Rodgers GM. Superwarfarin poisoning: a report of two cases and review of the literature. Am J Hematol 2007;82:656-660.
DOI
ScienceOn
|
| 5 |
Waien SA, Hayes D Jr, Leonardo JM. Severe coagulopathy as a consequence of smoking crack cocaine laced with rodenticide. N Engl J Med 2001;345:700-701.
|
| 6 |
Laposata M, Van Cott EM, Lev MH. Case records of the Massachusetts General Hospital: case 1-2007: a 40-yearold woman with epistaxis, hematemesis, and altered mental status. N Engl J Med 2007;356:174-182.
DOI
ScienceOn
|
| 7 |
Bachmann KA, Sullivan TJ. Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin- sensitive rats. Pharmacology 1983;27:281-288.
DOI
|
| 8 |
Weitzel JN, Sadowski JA, Furie BC, et al. Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases. Blood 1990;76:2555-2559.
|
| 9 |
Sharma P, Bentley P. Of rats and men: superwarfarin toxicity. Lancet 2005;365:552-553.
DOI
ScienceOn
|
| 10 |
Lipton RA, Klass EM. Human ingestion of a 'superwarfarin' rodenticide resulting in a prolonged anticoagulant effect. JAMA 1984;252:3004-3005.
DOI
ScienceOn
|
| 11 |
Misra D, Bednar M, Cromwell C, Marcus S, Aledort L. Manifestations of superwarfarin ingestion: a plea to increase awareness. Am J Hematol 2010;85:391-392.
|
| 12 |
Pavlu J, Harrington DJ, Voong K, Savidge GF, Jan-Mohamed R, Kaczmarski R. Superwarfarin poisoning. Lancet 2005;365:628.
DOI
ScienceOn
|
| 13 |
Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427:537-541.
DOI
ScienceOn
|
| 14 |
Hong J, Yhim HY, Bang SM, et al. Korean patients with superwarfarin intoxication and their outcome. J Korean Med Sci 2010;25:1754-1758.
DOI
ScienceOn
|
| 15 |
Lee HJ, You MR, Moon WR, et al. Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum. Korean J Intern Med 2014;29:498-508.
DOI
ScienceOn
|
webmaster
